tolvaptan has been researched along with ticagrelor in 1 studies
Studies (tolvaptan) | Trials (tolvaptan) | Recent Studies (post-2010) (tolvaptan) | Studies (ticagrelor) | Trials (ticagrelor) | Recent Studies (post-2010) (ticagrelor) |
---|---|---|---|---|---|
967 | 172 | 786 | 2,425 | 594 | 2,246 |
Protein | Taxonomy | tolvaptan (IC50) | ticagrelor (IC50) |
---|---|---|---|
P2Y purinoceptor 13 | Homo sapiens (human) | 1.398 | |
P2Y purinoceptor 12 | Homo sapiens (human) | 1.1028 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Maggioni, AP | 1 |
1 other study(ies) available for tolvaptan and ticagrelor
Article | Year |
---|---|
[Multination clinical trials: what is the relevance and what are the lessons from across-country differences?].
Topics: Acute Coronary Syndrome; Adenosine; Americas; Benzazepines; Cardiovascular Agents; Cardiovascular Diseases; Clinical Trials as Topic; Clopidogrel; Ethnicity; Europe; Female; Georgia (Republic); Heart Failure; Humans; Internationality; Male; Metoprolol; Multicenter Studies as Topic; Platelet Aggregation Inhibitors; Russia; Sample Size; Spironolactone; Ticagrelor; Ticlopidine; Tolvaptan | 2014 |